EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge

N J Campion iD, S Villazala-Merino, C Morgenstern iD, L Nemec, V Stanek, A Tu iD, M Zghaebi, J Toth, R Fröschl, T Perkmann, M Bastl, K Gangl und 7 weitere

Allergy · 2026-11 · 81 (11) · 3920-3935

DOI: 10.1111/all.70365 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Allergy, online erschienen am 04.05.2026. Verfasst von N J Campion und 18 weiteren Autor:innen. Beteiligte Einrichtung: Vienna Airway Lab, Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Betula, Allergens, Rhinitis, Allergic, Seasonal, Plant Extracts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, DANUBE ARC program of the county of Lower Austria..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In allergic rhinitis (AR), effector cell activation via allergen‐specific (s) IgE cross‐linking is well established, yet the in vivo kinetics of allergen‐specific antibody responses and their modulation of effector cell reactivity after nasal allergen exposure warrant further investigation. We therefore set out to characterize the sequence and timing of systemic and local antibody responses and basophil/mast cell sensitivity after nasal allergen challenge, and their influence on subsequent seasonal responses.

Methods

In this randomized, double‐blind, placebo‐controlled trial, birch pollen–allergic adults received three daily nasal challenges with birch pollen extract ( n = 20) or placebo ( n = 10) in autumn. sIgE, sIgG, sIgG1, sIgG4 and sIgA levels, basophil activation (BAT), and titrated skin prick test (tSPT) responses were measured biweekly in nasal mucosal lining fluid (nMLF), blood and skin for 3 months, and before, during, and after seasonal exposure.

Results

Allergen but not placebo challenge induced sequential sIgE rises, first in serum, then nMLF, mirrored by sIgG responses. Basophil sensitivity peaked with serum sIgE at 4 weeks, followed by maximal mast cell sensitivity in tSPT at 8 weeks. Allergen‐specific antibodies remained elevated through the pre‐seasonal and seasonal periods. Allergen‐challenged subjects showed reduced sIgE rise and lower effector cell sensitivity during the following pollen season.

Conclusion

Out‐of‐season high‐dose nasal allergen exposure enhances sIgE levels and effector cell sensitivity as well as sIgG and nasal sIgA responses. The latter appear to later attenuate seasonal amplification of allergic responses. Trial Registration ClinicalTrials.gov ID: NCT03644680

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BetulaAllergensRhinitis, Allergic, SeasonalPlant ExtractsAntibody FormationHumansFemaleBasophilsImmunoglobulin EAdultMaleNasal Provocation TestsPollenMast CellsSkin TestsDouble-Blind MethodKineticsYoung Adult

Stichwörter der Autor:innen

allergic rhinitisbirch pollen allergylate allergic responselocal allergic responsenasal challengesystemic allergic response

Substanzen

AllergensImmunoglobulin EPlant Extracts

Autor:innen und Institutionen

  • Vienna Airway Lab, Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria.
  • Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Center for Molecular Allergology, Karl Landsteiner University of Health Sciences, Krems, Austria.

ORCID-Profile: N J Campion, C Morgenstern, A Tu, S Schneider, R Ristl, R Valenta

Förderung

  • Austrian Science Fund
  • DANUBE ARC program of the county of Lower Austria.

Zitieren

APA

Campion, N. J., Villazala-Merino, S., Morgenstern, C., Nemec, L., Stanek, V., Tu, A., Zghaebi, M., Toth, J., Fröschl, R., Perkmann, T., Bastl, M., Gangl, K., Schneider, S., Breiteneder, H., Ristl, R., Focke-Tejkl, M., Valenta, R., Niederberger-Leppin, V., & Eckl-Dorna, J. (2026). Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge. Allergy, 81(11), 3920-3935. https://doi.org/10.1111/all.70365

Vancouver

Campion NJ, Villazala-Merino S, Morgenstern C, Nemec L, Stanek V, Tu A, et al. Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge. Allergy. 2026;81(11):3920-3935. doi:10.1111/all.70365

BibTeX
@article{Campion2026,
  author = {Campion, N J and Villazala-Merino, S and Morgenstern, C and Nemec, L and Stanek, V and Tu, A and Zghaebi, M and Toth, J and Fröschl, R and Perkmann, T and Bastl, M and Gangl, K and Schneider, S and Breiteneder, H and Ristl, R and Focke-Tejkl, M and Valenta, R and Niederberger-Leppin, V and Eckl-Dorna, J},
  title = {Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge},
  journal = {Allergy},
  year = {2026},
  volume = {81},
  number = {11},
  pages = {3920--3935},
  doi = {10.1111/all.70365}
}
Kostenlos starten →